CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,270 | -19.1% | 50 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $2,807 | -97.0% | 50 | -97.6% | 0.00% | -95.5% |
Q1 2023 | $92,722 | +356.2% | 2,050 | +310.0% | 0.02% | +340.0% |
Q4 2022 | $20,325 | -38.4% | 500 | 0.0% | 0.01% | -44.4% |
Q3 2022 | $33,000 | +10.0% | 500 | 0.0% | 0.01% | +12.5% |
Q2 2022 | $30,000 | -73.5% | 500 | -72.2% | 0.01% | -69.2% |
Q1 2022 | $113,000 | +41.2% | 1,800 | +71.4% | 0.03% | +62.5% |
Q4 2021 | $80,000 | +29.0% | 1,050 | +90.9% | 0.02% | +23.1% |
Q3 2021 | $62,000 | +313.3% | 550 | +450.0% | 0.01% | +225.0% |
Q4 2020 | $15,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |